N-Methyl-2-(1-methyl-1H-indol-3-yl)-N-(4-phenoxybenzyl)-ethanamine

ID: ALA3785628

Chembl Id: CHEMBL3785628

PubChem CID: 127031897

Max Phase: Preclinical

Molecular Formula: C25H26N2O

Molecular Weight: 370.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCc1cn(C)c2ccccc12)Cc1ccc(Oc2ccccc2)cc1

Standard InChI:  InChI=1S/C25H26N2O/c1-26(17-16-21-19-27(2)25-11-7-6-10-24(21)25)18-20-12-14-23(15-13-20)28-22-8-4-3-5-9-22/h3-15,19H,16-18H2,1-2H3

Standard InChI Key:  XPQXULVNJPNTCK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3785628

    ---

Associated Targets(non-human)

Trpa1 Transient receptor potential cation channel subfamily A member 1 (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trpv1 Transient receptor potential cation channel subfamily V member 1 (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trpm8 Transient receptor potential cation channel subfamily M member 8 (202 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.50Molecular Weight (Monoisotopic): 370.2045AlogP: 5.65#Rotatable Bonds: 7
Polar Surface Area: 17.40Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.44CX LogP: 5.75CX LogD: 3.72
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.42Np Likeness Score: -0.95

References

1. Bertamino A, Ostacolo C, Ambrosino P, Musella S, Di Sarno V, Ciaglia T, Soldovieri MV, Iraci N, Fernandez Carvajal A, de la Torre-Martinez R, Ferrer-Montiel A, Gonzalez Muniz R, Novellino E, Taglialatela M, Campiglia P, Gomez-Monterrey I..  (2016)  Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators.,  59  (5): [PMID:26847872] [10.1021/acs.jmedchem.5b01914]

Source